Salma Malik
Royal Hospital for Sick Children
6 Papers
32 Citations
Salma Malik is an academic researcher from Royal Hospital for Sick Children. The author has contributed to research in topics: Inflammatory bowel disease & Medicine. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
Improvement in growth of children with Crohn disease following anti-TNF-α therapy can be independent of pubertal progress and glucocorticoid reduction.
Salma Malik,Sze Choong Wong,J. Bishop,K Hassan,Paraic McGrogan,Syed Faisal Ahmed,Richard K Russell +6 more
TL;DR: Clinical response to infliximab therapy is associated with an improvement in linear growth in the short term in children with CD, and this increase in height may not be simply due to progress in pubertal status or reduction in GC dose.
78
Impact of inflammatory bowel disease on pubertal growth
TL;DR: Disorders of pubertal growth are more likely to occur in Crohn’s disease and, particularly, in boys.
51
The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD)
Salma Malik,Syed Faisal Ahmed,Michelle Wilson,Neil Shah,S Loganathan,Sandhia Naik,Billy Bourke,Adrian G. Thomas,Anthony K Akobeng,Andrew Fagbemi,David C. Wilson,Richard K Russell +11 more
TL;DR: Clinical response to adalimumab therapy is associated with an improvement in linear growth in a proportion of children with CD, and improved growth is more likely in patients entering remission and on immunosuppression but is not solely due to a steroid sparing effect.
50
A prospective longitudinal study of growth and pubertal progress in adolescents with inflammatory bowel disease.
Avril Mason,Salma Malik,Martin McMillan,Jane McNeilly,Jeffrey R. Bishop,Paraic McGrogan,Richard K. Russell,S Faisal Ahmed +7 more
TL;DR: Adolescents with IBD display growth retardation which may be associated with raised ESR, adverse quality of life measures and an abnormality of IGF-1 bioavailability.
35
Growth in children receiving contemporary disease specific therapy for Crohn's disease
Salma Malik,Avril Mason,Andisheh Bakhshi,David Young,Jonathan Bishop,Victoria Garrick,Paraic McGrogan,Richard K Russell,S Faisal Ahmed +8 more
TL;DR: Although current therapy for CD is associated with improved rate of growth for the first few years, a substantial proportion of children remain short and this study highlights the need for consistency in describing growth in children with chronic diseases.
33